Tesla To $230? Plus Canaccord Genuity Cuts PT On T2 Biosystems By 80%

Wells Fargo cut the price target onTesla, Inc.from $280 to $230. Wells Fargo analyst Colin Langan maintained an Equal-Weight rating on the stock. Tesla shares fell 0.4% to $220.85 in pre-market trading.Canaccord Genuity cut the price target forT2 Biosystems, Inc.from $12.5 to $2.5. Canaccord Genuity analyst Kyle Mikson downgraded the stock from Buy to Hold. T2 Biosystems shares fell 4.7% to $2.43 in pre-market trading.Keybanc cut the price target onMSC Industrial Direct Co., Inc.from $100 to $93
Tesla To $230? Plus Canaccord Genuity Cuts PT On T2 Biosystems By 80%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment1

  • Top
  • Latest
  • Liontrader
    ·2022-10-15
    Coming thruuuuu [Grin][Grin][Grin]
    Reply
    Report